Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

697 ARTÍCULOS , VIENDO DEL 511 AL 525

Developing blood-brain barrier arterial spin labelling as a non-invasive early biomarker of Alzheimer's disease (DEBBIE-AD): a prospective observational multicohort study protocol

Padrela B, Mahroo A, Tee M, Sneve MH, Moyaert P, Geier O, Kuijer JPA, Beun S, Nordhøy W, Zhu YD, Buck MA, Hoinkiss DC, Konstandin S, Huber J, Wiersinga J, Rikken R, de Leeuw D, Grydeland H, Tippett L, Cawston EE, Ozturk-Isik E, Linn J, Brandt M, Tijms BM, van de Giessen EM, Muller M, Fjell A, Walhovd K, Bjørnerud A, Pålhaugen L, Selnes P, Clement P, Achten E, Anazodo U, Barkhof F, Hilal S, Fladby T, Eickel K, Morgan C, Thomas DL, Petr J, Günther M, Mutsaerts HJMM.

BMJ Open. 2024 Mar 8;14(3):e081635. doi: 10.1136/bmjopen-2023-081635.

A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer's disease

Zhang Y, Xue L, Zhang S, Yang J, Zhang Q, Wang M, Wang L, Zhang M, Jiang J, Li Y; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2024 Mar 14;16(1):60. doi: 10.1186/s13195-024-01425-8.

Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review

Cabrera-León Y, Báez PG, Fernández-López P, Suárez-Araujo CP.

J Alzheimers Dis. 2024;98(3):793-823. doi: 10.3233/JAD-231271.

Soluble Biomarkers of Cerebrovascular Pathologies

Foley KE, Wilcock DM.

Stroke. 2024 Apr;55(4):801-811. doi: 10.1161/STROKEAHA.123.044172. Epub 2024 Mar 25.

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease

Gonzalez-Ortiz F, Kirsebom BE, Contador J, Tanley JE, Selnes P, Gísladóttir B, Pålhaugen L, Suhr Hemminghyth M, Jarholm J, Skogseth R, Bråthen G, Grøndtvedt G, Bjørnerud A, Tecelao S, Waterloo K, Aarsland D, Fernández-Lebrero A, García-Escobar G, Navalpotro-Gómez I, Turton M, Hesthamar A, Kac PR, Nilsson J, Luchsinger J, Hayden KM, Harrison P, Puig-Pijoan A, Zetterberg H, Hughes TM, Suárez-Calvet M, Karikari TK, Fladby T, Blennow K.

Nat Commun. 2024 Apr 4;15(1):2908. doi: 10.1038/s41467-024-47286-5.

Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment

Lehmann S, Schraen-Maschke S, Vidal JS, Delaby C, Buee L, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Hanon O; BALTAZAR study group.

J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1046-1053. doi: 10.1136/jnnp-2024-333467.

Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease

Duff K, Hammers DB, Koppelmans V, King JB, Hoffman JM.

J Alzheimers Dis. 2024;99(1):321-332. doi: 10.3233/JAD-231392.

Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study

Souchet B, Michaïl A, Heuillet M, Dupuy-Gayral A, Haudebourg E, Pech C, Berthemy AA, Autelitano F, Billoir B, Domoto-Reilly K, Fowler C, Grabowski T, Jayadev S, Masters CL, Braudeau J.

J Prev Alzheimers Dis. 2024;11(3):567-581. doi: 10.14283/jpad.2024.34.

Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer's Disease between the Chinese and European Populations

Li F, Xie S, Cui J, Li Y, Li T, Wang Y, Jia J.

J Prev Alzheimers Dis. 2024;11(3):701-709. doi: 10.14283/jpad.2024.29.

Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

Dakterzada F, Cipriani R, López-Ortega R, Arias A, Riba-Llena I, Ruiz-Julián M, Huerto R, Tahan N, Matute C, Capetillo-Zarate E, Piñol-Ripoll G.

Int J Mol Sci. 2024 Apr 23;25(9):4594. doi: 10.3390/ijms25094594.

Progress on early diagnosing Alzheimer's disease

Chen Y, Al-Nusaif M, Li S, Tan X, Yang H, Cai H, Le W.

Front Med. 2024 Jun;18(3):446-464. doi: 10.1007/s11684-023-1047-1. Epub 2024 May 21.

Alzheimer disease blood biomarkers: considerations for population-level use

Mielke MM, Fowler NR.

Nat Rev Neurol. 2024 Aug;20(8):495-504. doi: 10.1038/s41582-024-00989-1. Epub 2024 Jun 11.

TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer's disease

Vuoksimaa E, Saari TT, Aaltonen A, Aaltonen S, Herukka SK, Iso-Markku P, Kokkola T, Kyttälä A, Kärkkäinen S, Liedes H, Ollikainen M, Palviainen T, Ruotsalainen I, Toivola A, Urjansson M, Vasankari T, Vähä-Ypyä H, Forsberg MM, Hiltunen M, Jalanko A, Kälviäinen R, Kuopio T, Lähteenmäki J, Nyberg P, Männikkö M, Serpi R, Siltanen S, Palotie A, Kaprio J, Runz H, Julkunen V; FinnGen.

BMJ Open. 2024 Jun 12;14(6):e081947. doi: 10.1136/bmjopen-2023-081947.

AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers - A narrative review of a growing field

Rudroff T, Rainio O, Klén R.

Neurol Sci. 2024 Nov;45(11):5117-5127. doi: 10.1007/s10072-024-07649-8. Epub 2024 Jun 13.

Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study

Soleimani-Meigooni DN, Smith R, Provost K, Lesman-Segev OH, Allen IE, Chen MK, Cho H, Edwards L, Janelidze S, La Joie R, Mundada N, Ossenkoppele R, Stomrud E, Strandberg O, Strom A, Boxer AL, Dage JL, Gorno-Tempini ML, Kramer JH, Miller BL, Rojas JC, Rosen HJ, Lyoo CH, Hansson O, Rabinovici GD.

Ann Neurol. 2024 Sep;96(3):476-487. doi: 10.1002/ana.27008. Epub 2024 Jun 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias